Optimisation of chemotherapy prescription and preparation in an ambulatory unit: Validation of the OPTIMA program
Autor: | Jean-Michel Grellard, Audrey Faveyrial, Kelly Lavergne, Sébastien Jaffré, Bénédicte Clarisse, Marie-Pierre Galais, Audrey Emmanuelle Dugué, Fabienne Divanon, Mélanie Dos Santos, Lucie Laroche, Justine Lequesne, Céline Ory, Corinne Delcambre, Anaïs Lelaidier |
---|---|
Rok vydání: | 2019 |
Předmět: |
Adult
Male Waiting time medicine.medical_specialty Time Factors medicine.medical_treatment Antineoplastic Agents 03 medical and health sciences 0302 clinical medicine Neoplasms Ambulatory Care medicine Humans Prospective Studies Medical prescription Quality of care Prospective cohort study Aged Quality of Health Care Chemotherapy business.industry Intravenous chemotherapy Middle Aged Regimen Oncology Patient Satisfaction 030220 oncology & carcinogenesis Emergency medicine Ambulatory Female business Delivery of Health Care |
Zdroj: | European Journal of Cancer Care. 28 |
ISSN: | 1365-2354 0961-5423 |
DOI: | 10.1111/ecc.13015 |
Popis: | OBJECTIVE We implemented the two-step OPTIMA program to anticipate chemotherapy prescription which aims to assess the discrepancy rate between anticipated and real prescription and its impact on waiting time and quality of care. METHODS This prospective study included cancer patients receiving any intravenous chemotherapy. The OPTIMA program consists in a nurse phone call and a blood sample two days before the planned treatment. Collected information and biological results were used by a physician to issue a non-effective (step 1) or effective (step 2) anticipated prescription the day before the consultation. The real prescription was given as usual by another physician on the day of the consultation. Waiting time was collected, and patients' satisfaction with care was assessed with the OUT-PATSAT35 questionnaire. RESULTS Respectively, 540 and 979 consultations (283 and 294 patients) were analysed in both steps. The discrepancy rate was 8.7% (step 1). In routine practice, the OPTIMA program (step 2) reduced patients' waiting time (median time 55 vs. 95 min, p |
Databáze: | OpenAIRE |
Externí odkaz: |